Bubu Banini, MD, PhD

Overview of interim findings from a Survey on Patient Attitudes Toward Clinical Trial Processes In Chronic Liver Diseases

Glp1-agonist reduces alcohol intake and liver inflammation in a mouse model of alcohol-induced acute hepatitis.

Sex-based Disparities in Baseline Characteristics and Clinical Outcomes of patients with Decompensated Cirrhosis and Hepatic Hydrothorax

Prevalence of nonalcoholic fatty liver disease among adults with normal weight, overweight and obesity in the United States, 1999-2018.

A Case of Late-Onset Hepatic Sinusoidal Obstructive Syndrome/ Veno-occlusive Disease 1 Year Post Transplant.

Regional Variation in Baseline Characteristics and Clinical Outcomes of Decompensated Cirrhosis with Hepatic Hydrothorax

Alcohol and Liver Health

Hepatic hydrothorax portends worse inpatient outcomes in patients with decompensated cirrhosis

Pathways to GI Panel

Teens to Twenties Liver Wellness Guide

Metabolic features associated with nonalcoholic fatty liver disease among Asian-Americans, 2012-2018

Insulin resistance trends among lean patients with nonalcoholic fatty liver disease in the United States

Prognostic mitochondrial ribosomal protein MRPS30 expression in liver cancer: toward new biomarkers in metabolic liver disease

Pharmacotherapy for Weight loss in cirrhosis: A case series of GLP-1 agonist-associated weight loss

New Frontiers for Fatty Liver Disease: Updates on Clinical Trials and Drug Approval Status

STEM Professionals Speaker Series

Transient Elastography and FIB-4 Identify Portal Hypertension in Patients with Chronic Liver Disease

Haptoglobin 2 allele is associated with increased risk and severity of alcoholic hepatitis

Non-alcoholic fatty liver disease is associated with QTc lengthening in the general population

Enlarging Ectopic Thyroid in the Porta Hepatis

Acceleration of NASH in a mouse model provides novel insights on the mechanisms by which I148M PNPLA3 drives steatohepatitis

The Physiological, Pathological and Molecular Basis of Nonalcoholic Steatohepatitis Associated Cardiomyopathy

Key molecular signatures of disease development and progression in non-alcoholic fatty liver disease in humans.

Collagen formation and degradation biomarkers identify advanced fibrosis in NASH patients

Nonalcoholic Steatohepatitis (NASH) has surpassed Hepatitis C as the leading etiology for listing for liver transplant: implications for NASH in children and young adults

Omega-3 Carboxylic Acids, Epanova®, and the Sodium-Glucose Co-transporter 2 Inhibitor, Dapagliflozin®, improve steatohepatitis and fibrosis scoring in a mouse model of NASH

Characterization of sulfatase 2 domains regulating Wnt pathway activity in hepatocellular cancer

Colorectal Cancer Screening Among Outpatients at a Community-Based Teaching Hospital

Increasing Fetal Hemoglobin as Therapy for Sickle Cell Disease

Early Sodium Butyrate Treatment Maximally Increases Fetal Hemoglobin in Differentiating Adult Erythroid Cells

Effect of Thyroid Hormone on Erythroid Maturation of Human Hematopoietic Progenitors

Studies of Globin-Gene Regulation through Examination of Gene Expression Profiling and Chromatin Occupancy.

Identification of Regulators of Globin-Gene Expression through Studies of Chromatin Occupancy.

Disruption of Gαs Signaling Alters Courtship Memory in Drosophila